牙周治疗对唾液细胞外囊泡货物影响的探索性研究
该探索性研究纳入25例III-IV期牙周炎患者,在非手术牙周治疗(NSPT)前、治疗后3个月和6个月采集唾液,分析宿主细胞外囊泡(EV)亚群及细胞因子货物。结果显示临床指标显著改善,6个月时CD63+、CD24+、CD142+宿主EV及EV相关IL-6、IL-2降低,IL-5和IL-10升高;应答不佳者T1时CD81+、CD326+、CD45+、CD133+宿主EV表达更高。
要点
- NSPT后3和6个月PPD、CAL、BOP、PI较基线显著改善(p<0.05)。
- 6个月时CD63+、CD24+、CD142+宿主EV及EV相关IL-6、IL-2较基线降低,IL-5、IL-10升高。
- 应答不佳者T1时CD81+、CD326+、CD45+、CD133+宿主EV表达高于应答者。
核心结论
- NSPT带来临床改善的同时伴随唾液宿主EV组成及细胞因子货物的变化。
- 唾液宿主EV亚群和细胞因子谱可能作为监测牙周炎治疗结果的生物标志物。
研究设计与样本
- 探索性研究,招募25例III-IV期牙周炎患者。
- 在基线、NSPT后3个月(T1)和6个月(T2)采集非刺激唾液。
- 记录PPD、CAL、BOP、PI临床参数,采用基于珠的免疫亲和捕获法分离唾液宿主EV并分析亚群标志物和细胞因子货物。
主要发现
- T1和T2时PPD、CAL、BOP、PI较基线显著改善(p<0.05)。
- 亚组分析识别出5例应答不佳者,在T1和T2持续存在深牙周袋(≥4个位点≥5 mm)。
- 6个月时CD63+、CD24+、CD142+宿主EV及宿主EV相关IL-6、IL-2较基线降低,IL-5和IL-10升高。
- 应答不佳者T1时CD81+、CD326+、CD45+、CD133+宿主EV表达高于应答者。
临床怎么用
- 唾液宿主EV亚群及细胞因子货物变化可能用于监测牙周炎NSPT疗效。
- 应答不佳者特定EV亚群表达升高,或有助于早期识别治疗反应欠佳患者。
局限性
- 探索性研究,样本量25例,结论需更大样本验证。
- 仅识别5例应答不佳者,亚组分析结果需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To investigate longitudinal changes in salivary extracellular vesicle (EV) sub-populations and their associated cytokine profiles following non-surgical periodontal therapy (NSPT) in patients with Stage III-IV periodontitis. MATERIALS AND METHODS: This exploratory study recruited 25 patients, and unstimulated saliva samples were collected at baseline, 3 months (T1) and 6 months (T2) post-NSPT. Clinical parameters, including probing pocket depth (PPD), clinical attachment loss (CAL), bleeding on probing (BOP) and plaque index (PI), were recorded. Salivary host EVs were isolated using bead-based immunoaffinity capture method and analysed for sub-population markers and cytokine cargo. RESULTS: Significant improvements in PPD, CAL, BOP and PI were observed at T1 and T2 compared to baseline (p < 0.05). Subgroup analysis identified five suboptimal responders with persistent deep pockets (≥ 4 sites with ≥ 5 mm) at T1 and T2. At 6 months, levels of CD63+, CD24+ and CD142+ host EVs, as well as host EV-associated interleukin (IL)-6 and IL-2, were reduced compared to baseline, while IL-5 and IL-10 levels were elevated. Our exploratory analysis showed that suboptimal responders exhibited higher expressions of CD81+, CD326+, CD45+ and CD133+ host EVs at T1 compared to responders. CONCLUSIONS: This exploratory study demonstrated that NSPT led to clinical improvements accompanied by changes in the composition and cytokine cargo of salivary host EVs. Alterations in salivary host EV sub-populations and cytokine profiles may have potential utility as biomarkers for monitoring treatment outcomes in periodontitis.
引用
- Wang J, Liu C, Lai A, et al. Effect of Periodontal Therapy on Salivary Extracellular Vesicle Cargos: An Exploratory Study. J Clin Periodontol. 2025. PMID: 41145301. doi:10.1111/jcpe.70051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。